Spatial and temporal distribution of dopaminergic neurons during development in zebrafish

Spatial and temporal distribution of dopaminergic neurons during development in zebrafish

As one of the model organisms of Parkinson’s disease (PD) research, the zebrafish has its advantages, such as the 87% homology with human genome and transparent embryos which make it possible to observe the development of dopaminergic neurons in real time. However, there is no midbrain dopaminergic...

Full description

Bibliographic Details
Main Authors:	Yuchen Du, Qiang Guo, Minghui Shan, Yongmei Wu, Sizhou Huang, Haixia Zhao, Huarong Hong, Ming Yang, Xi Yang, Liyi Ren, Jiali Peng, Jing Sun, Hongli Zhou, Shurong Li, Bingyin Su
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-11-01
Series:	Frontiers in Neuroanatomy
Subjects:	Dopamine Zebrafish development distribution Parkinson’s disease projection
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnana.2016.00115/full

Similar Items

Effects of different concentrations of dimethylsulfoxide on development of zebrafish embryos and dopamine neurons
by: GAN Jinfan, et al.
Published: (2019-08-01)

Neuroprotective Effects of Ascorbic Acid, Vanillic Acid, and Ferulic Acid in Dopaminergic Neurons of Zebrafish
by: Fatemeh Hedayatikatouli, et al.
Published: (2024-10-01)

Cerebroventricular Microinjections of MPTP on Adult Zebrafish Induces Dopaminergic Neuronal Death, Mitochondrial Fragmentation, and Sensorimotor Impairments
by: Michael Kalyn, et al.
Published: (2021-08-01)

Rotenone Neurotoxicity Causes Dopamine Neuron Loss in Zebrafish
by: Simon Martel, et al.
Published: (2015-11-01)

Nanodiamond-mediated delivery of microRNA-7 for the neuroprotection of dopaminergic neurons
by: Yuping Han, et al.
Published: (2025-01-01)

Keluwih (Artocarpus camansi) extract effects in zebrafish models of Parkinson’s disease
by: Marisca Evalina Gondokesumo, et al.
Published: (2023-05-01)

Dopaminergic modulation of synaptic transmission and neuronal activity patterns in the zebrafish homolog of olfactory cortex
by: Yan-Ping eZhang Schärer, et al.
Published: (2012-10-01)

Dopaminergic control of locomotor patterning during development: a tail for the agesCommentary: "Firing dynamics and modulatory actions of supraspinal dopaminergic neurons during zebrafish locomotor behavior"
by: Aaron Matthew Lambert, et al.
Published: (2016-04-01)

Evaluation of spontaneous propulsive movement as a screening tool to detect rescue of Parkinsonism phenotypes in zebrafish models
by: Thomas C. Farrell, et al.
Published: (2011-10-01)

Degeneration of dopaminergic neurons and impaired intracellular trafficking in Atp13a2 deficient zebrafish
by: Hiromi Nyuzuki, et al.
Published: (2020-12-01)

Developmental pathways linked to the vulnerability of adult midbrain dopaminergic neurons to neurodegeneration
by: Nilima Prakash
Published: (2022-12-01)

Developmental and behavioral toxicity assessment of opicapone in zebrafish embryos
by: Zhengkang Su, et al.
Published: (2023-01-01)

The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons
by: Hakeem O. Lawal, et al.
Published: (2010-10-01)

Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish
by: Ville Sallinen, et al.
Published: (2010-10-01)

Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment
by: Maria-Joao Ribeiro, et al.
Published: (2020-08-01)

The Cerebellar Dopaminergic System
by: Paolo Flace, et al.
Published: (2021-08-01)

Dendritic involvement in inhibition and disinhibition of vulnerable dopaminergic neurons in healthy and pathological conditions
by: R.C. Evans
Published: (2022-10-01)

THE INTRACELLULAR SIGNALING MOLECULE DARPP-32 IS A MARKER FOR PRINCIPAL NEURONS IN THE CEREBELLUM AND CEREBELLUM-LIKE CIRCUITS OF ZEBRAFISH.
by: Lena Robra, et al.
Published: (2016-08-01)

Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons
by: Steven M. Graves, et al.
Published: (2021-08-01)

LONG-TERM DOPAMINERGIC THERAPY OF PARKINSON DISEASE
by: O. S. Levin
Published: (2017-05-01)

Parkinson’s disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022-09-01)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
by: Georgia Minakaki, et al.
Published: (2020-12-01)

Modeling ferroptosis in human dopaminergic neurons: Pitfalls and opportunities for neurodegeneration research
by: Nadine Renner, et al.
Published: (2024-07-01)

Serotonergic and dopaminergic neurons in the dorsal raphe are differentially altered in a mouse model for parkinsonism
by: Laura Boi, et al.
Published: (2024-06-01)

Neurochemical measurements in the zebrafish brain
by: Lauren eJones, et al.
Published: (2015-09-01)

Identification of minimum essential therapeutic mixtures from cannabis plant extracts by screening in cell and animal models of Parkinson’s disease
by: Michael G. Morash, et al.
Published: (2022-10-01)

Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
by: Jinyuan Yan, et al.
Published: (2019-06-01)

Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson’s disease-like motor dysfunction
by: Yukari Suda, et al.
Published: (2018-02-01)

Live imaging of mitochondrial dynamics in CNS dopaminergic neurons in vivo demonstrates early reversal of mitochondrial transport following MPP+ exposure
by: April A. Dukes, et al.
Published: (2016-11-01)

Morpho-Anatomical Degeneration of Dopaminergic Neurons in Adult Zebrafish Brain after Exposure to Nickel
by: Pietro Cacialli, et al.
Published: (2024-08-01)

Brain renin-angiotensin system and dopaminergic cell vulnerability
by: Jose L Labandeira-Garcia, et al.
Published: (2014-07-01)

The opioid agonist morphine decreases the dyskinetic response to dopaminergic agents in parkinsonian monkeys
by: Pershia Samadi, et al.
Published: (2004-06-01)

Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT
by: Maged M. Harraz, et al.
Published: (2023-08-01)

Dopaminergic Neurons in Zona Incerta Drives Appetitive Self‐Grooming
by: Zhiying Jiang, et al.
Published: (2024-09-01)

Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons
by: Domingo eAfonso-Oramas, et al.
Published: (2014-08-01)

Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity
by: Juan Segura-Aguilar, et al.
Published: (2022-01-01)

Sexual dysfunction precedes motor defects, dopaminergic neuronal degeneration, and impaired dopamine metabolism: Insights from Drosophila model of Parkinson’s disease
by: Zevelou Koza, et al.
Published: (2023-03-01)

Dose-Dependent and Subset-Specific Regulation of Midbrain Dopaminergic Neuron Differentiation by LEF1-Mediated WNT1/b-Catenin Signaling
by: Parivash Nouri, et al.
Published: (2020-10-01)

Zebrafish Shoaling, Its Behavioral and Neurobiological Mechanisms, and Its Alteration by Embryonic Alcohol Exposure: A Review
by: Amanda Facciol, et al.
Published: (2020-09-01)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson’s Disease
by: Ioannis Ugo Isaias, et al.
Published: (2016-08-01)